V1bio
V1bio Inc. is a biotechnology company focused on creating a healthy one-health ecosystem through innovative microbiome therapies. The company develops immune and anti-cancer treatments as well as animal health nutrition products using one-health microbiomes. Their proprietary platform includes a one-health microbiome library, AI and BI-based microbiome profiling, multi-omics analysis, and translational research. V1bio targets live biotherapeutic products in oncology and immunology for both humans and animals. They emphasize open collaboration through research partnerships, in-licensing, and out-licensing to accelerate development. Based in Seoul, South Korea, V1bio aims to revolutionize patient lives globally by leveraging cutting-edge microbiome technology and research.
V1bio
V1bio Inc. is a biotechnology company focused on creating a healthy one-health ecosystem through innovative microbiome therapies. The company develops immune and anti-cancer treatments as well as animal health nutrition products using one-health microbiomes. Their proprietary platform includes a one-health microbiome library, AI and BI-based microbiome profiling, multi-omics analysis, and translational research. V1bio targets live biotherapeutic products in oncology and immunology for both humans and animals. They emphasize open collaboration through research partnerships, in-licensing, and out-licensing to accelerate development. Based in Seoul, South Korea, V1bio aims to revolutionize patient lives globally by leveraging cutting-edge microbiome technology and research.